WHC is still in active development. Read this to understand our approach.
depiction of RMEDXOLNCUSCGS-UHFFFAOYSA-N.svg
isomerdesign

Droperidol

Check on isomerdesign

pubchem

Droperidol

Check on pubchem

drugmap

Droperidol

Check on drugmap

wiki

Droperidol

Check on wiki

Data

InChI: InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)

Synonyms: Q174259,HMS1921B03,USS,Neurolidol,548-73-2,SPECTRUM1501002, Vetkalm,1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,Spectrum_001220, Sintosian,1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one,CCG-39004,NCGC00016504-05,HMS2051L06,DHBP,F17346, Component of Innovar,INAPSINE (TN),CHEBI:4717,W-105600,BSPBio_003132,NCGC00016504-03,Spectrum3_001426, Dihidrobenzperidol, Dridol (TN),Droleptan (TN),SPBio_002380,Leptanal (Salt/Mix),1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone,Ina.psi.ne,HMS3885N03,Dehydrobenzoperidol,KBio1_000103,Tox21_110461, Ina.psi.ne,SPBio_001372,NCGC00016504-02,Innovar-vet,Halkan,KBio2_001700,HMS3374B05, Leptanal,1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone,1-[1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, Innovar-vet,FT-0655846,DROPERIDOL [GREEN BOOK],NSC-757819,gamma-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-p-fluorobutyrophenone, Droleptan,CCRIS 9070, Inapsin,Droperidolum [INN-Latin],SR-05000001546-1, Droperidolum [INN-Latin], Sintodril,Prestwick1_000360,Ina.psi.n,Inopsin,HMS2096G21,Thalamanol, Droperidolum,DROPERIDOL [USP MONOGRAPH],Droleptan,2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-,DROPERIDOL [USAN],Tox21_110461_1,HMS2092O16,Thalamonal,1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one, Inappin, R-4749, Droleptan (TN),R4749,NSC 169874,DROPERIDOL [HSDB],SW220019-1,Leptofen,NSC-169874,NC00254, Deidrobenzperidolo,SCHEMBL41426,Inapsine, R4749,NCGC00016504-17,Droperidol (JP17/USP/INN),KBioSS_001700,NCGC00016504-01,DROPERIDOL [USP-RS],McN-JR-4749,Sintosian,DROPERIDOL [MI],MLS001424134,HY-B1240, Inapsine (TN),Leptofen (Salt/Mix),2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-,HMS3713G21,Innovar (Salt/Mix), 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one,1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-3H-benzoimidazol-2-one,DTXSID6022973,GTPL7172,5-24-02-00388 (Beilstein Handbook Reference),SBI-0051628.P002,2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-,UNII-O9U0F09D5X, Properidol,NCGC00094884-01, Droperidol (JP15/USP/INN),CS-4886, Dropletan (TN),Droperidol USP,Droperidol, British Pharmacopoeia (BP) Reference Standard,KBio2_006836,HMS1569G21,BSPBio_000459,NCGC00016504-09,1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, Innovan,NSC169874, R 4749, Dehydrobenzperidol,Droperidol, United States Pharmacopeia (USP) Reference Standard,MLS000758203,HSDB 3320,1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone,s4096,HMS3393L06, Inapsine,Inappin,1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one,BPBio1_000505,droperidol,CHEMBL1108,NINDS_000103,Spectrum2_001386,DB00450, 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone,DSSTox_CID_2973,1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one,Spectrum5_001305,WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF,R 4749, 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone,Innovar,HS-0065,548D732, Dridol,3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one,1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one,EN300-127036,Droperidol 1.0 mg/ml in Dimethyl Sulfoxide,1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,5,6-tetrahydropyridin-4-yl] -1,3-dihydro-2H-benzimidazol}-2-one,Sintodril,DROPERIDOL [EP MONOGRAPH], Inopsin,HMS3652M12,Dehydrobenzperidol,1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone,1-1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone,Prestwick_705,DROPERIDOL [ORANGE BOOK], Droperidolo [DCIT], Halkan,DSSTox_GSID_22973,A830387, McN-JR 4749,Innovar-vet (Salt/Mix),1-{1-[4-(4-Chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol),Thalamonal (Salt/Mix),1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]butan-1-one,BDBM50017705,ZINC19796080, Dehydrobenzoperidol,Droperidolo, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one,NCGC00094884-02,KBioGR_000674,KBio2_004268,NSC757819,Droperidol, European Pharmacopoeia (EP) Reference Standard,SR-05000001546,AC-3537,Droperidol [USAN:USP:INN:BAN:JAN],Droperidolum,1-(1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone,Opera_ID_1751,DROPERIDOL [JAN],AB00052191_04,Droperidol,Inapsin,CAS-548-73-2,DROPERIDOL [INN],KBio3_002352,BRN 0579168, HS-0065, Thalamonal,IDI1_000103,NCGC00016504-06,Innovan,SR-05000001546-3, Dehidrobenzperidol,DSSTox_RID_76811, Taylor Brand of Droperidol,Spectrum4_000407,Prestwick3_000360, 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz,Dridol,DROPERIDOL COMPONENT OF INNOVAR,MLS000028671,1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone,Prestwick0_000360, Leptofen,2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-,EINECS 208-957-8, Luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone,DivK1c_000103,3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one,Ino.psi.n,L001006, Droperidolo, Ina.psi.n,DROPERIDOL [MART.],STL453109,Inoval,SR-05000001546-2,component of Innovar, Kern Brand of Droperidol,MFCD00083290, Thalamanol,Dehidrobenzperidol,3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one,NCGC00016504-04,1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2h-benzimidazol-2-one,DROPERIDOL [VANDF], McN-JR-4749,AKOS015960779,AB00052191_05, INAPSINE (TN),INNOVAR COMPONENT DROPERIDOL,MLS002153445,O9U0F09D5X,HMS500F05, Inoval, 1-[1-[4-(p-F,Deidrobenzperidolo,1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone,CCG-101004, Droperidol [USAN:INN:BAN:JAN],Dihidrobenzperidol,Z1592690523,BRD-K97158071-001-08-2,Pharmakon1600-01501002,D00308,BRD-K97158071-001-05-8, Janssen Brand of Droperidol,3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-2,3,4,5-tetrahydropyridin-4-yl]-1~{H}-benzimidazol-2-one, Ino.psi.n,Properidol,Droperidolo [DCIT], 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone,Prestwick2_000360,HMS2232M09,SMR000058855,R-4749,McN-JR 4749,DROPERIDOL [WHO-DD],2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-,MLS001148120,Vetkalm


Estimated data

Solubility: -4.461 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 46.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.